Orrick Represents K5 Global in the $2.25 Billion Acquisition of HistoSonics

1 minute read | August.07.2025

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, announced the completion of a management-led majority stake acquisition by K5 Global and a syndicate of other globally recognized private and public investors, including Bezos Expeditions and Wellington Management. The transaction values HistoSonics at approximately $2.25 billion and will accelerate global expansion of the company’s breakthrough Edison® Histotripsy platform and non-invasive tumor therapy.

An Orrick team led by Max Cantor, Spencer Cohen and Matthew Gemello advised K5 Global. The team also included Joanna Pak, Vernon Lin, Ken Rasamny, Matt Janosko, Craig Falls, Kristin Petersen, Danielle Mangogna, Seojung Park, Jeanine McGuinness and Harry Clark.

Orrick ranked top 5 globally for buyouts by deal volume (Mergermarket) and M&A deal volume (LSEG) in 1H 2025.

LEARN MORE

Related Lawyers

Max Cantor Partner, Technology Companies Group, Mergers & Acquisitions

New York

See my bio

D:+1 212 506 3572
E: [email protected]

Practice:

Technology & Innovation Sector
Technology Companies Group
Mergers & Acquisitions
Fintech

vCard

See full bio

Max Cantor Partner

New York

Max has extensive experience in a broad range of domestic and cross-border corporate and transactional matters, including venture capital and growth equity financings, mergers & acquisitions and fund formation. He has represented both early and growth stage companies in hundreds of venture capital financings, growth equity investments and M&A transactions, and he regularly advises leading venture capital and private equity funds on their investments across the innovation ecosystem.

Max is recognized for his strategic counsel on corporate governance, boardroom matters, fundraising strategy and product development, serving as a trusted advisor and outside general counsel to clients around the world.

In addition to representing U.S. companies on domestic transactions, Max has substantial experience representing clients outside the U.S., including emerging companies and venture funds operating in Canada, Europe, Latin America, India, Japan, Singapore, China, Australia, Israel, the Cayman Islands and various other jurisdictions.

Spencer Cohen Partner, Mergers & Acquisitions, Private Equity

New York

See my bio

D:+1 212 506 3502
E: [email protected]

Practice:

Mergers & Acquisitions
Private Equity

vCard

See full bio

Spencer Cohen Partner

New York

Spencer represents private equity funds and their portfolio companies, as well as private and public companies in all aspects of their business.

Spencer regularly advises clients on a variety of strategic transitions, including domestic and cross-border M&A, debt and equity investments and joint ventures. He also counsels boards, investors and other key stakeholders on financing transactions and general corporate matters.

He works across a wide range of geographies and industries, including a primary focus in the tech, finance, life sciences, energy and infrastructure sectors.

Matthew Gemello Partner, Mergers & Acquisitions

Silicon Valley

See my bio

Practice:

Mergers & Acquisitions

vCard

See full bio

Matthew Gemello Partner

Silicon Valley

A seasoned deal lawyer, Matthew guides global technology companies and their financial sponsors through transformational domestic and cross-border transactions. These deals range from private company buyouts and public takeovers in the United States and around the world, to complex, multi-jurisdictional spinoffs and business carveouts.

Matthew has been recognized as a leading lawyer by numerous publications, including Legal 500 and he was selected by the San Francisco and Los Angeles Daily Journal as one of the top 10 Innovative Corporate Lawyers in California.